NCT07245719

Brief Summary

A retrospective post-market clinical follow-up to confirm the performance and safety of the Upper-Face and Mid-Face modules of the Stryker Universal CMF System in a clinical setting. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 28, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

August 7, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

November 24, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 27, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 27, 2026

Completed
Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

12 months

First QC Date

August 7, 2025

Last Update Submit

April 21, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Successful stabilization and/or fixation of bony segments without the need for unplanned revision surgery

    Assessed by reviewing adverse events in patient medical charts at time point after surgery. Used to document whether an unplanned revision surgery was required or not for patients.

    Data collected at a single time point per patient in the course of 12 months.

Secondary Outcomes (7)

  • Intraoperative complications

    Data collected at a single time point per patient in the course of 12 months.

  • Postoperative complications

    Data collected at time points per patient in the course of 12 months.

  • Any known adverse events potentially related to the primary outcome objective and/or device

    Data collected at time points per patient in the course of 12 months.

  • Implant failure

    Data collected at time points point per patient in the course of 12 months.

  • Operating room (OR) time

    Data collected at a single time point per patient in the course of 12 months.

  • +2 more secondary outcomes

Other Outcomes (18)

  • Age

    Data collected at a single time point per patient in the course of 12 months.

  • Primary indication for the surgery / diagnosis

    Data collected at a single time point per patient in the course of 12 months.

  • Surgical approach/access

    Data collected at a single time point per patient in the course of 12 months.

  • +15 more other outcomes

Interventions

The Universal CMF System is a plate and screw system intended for osteotomy, stabilization, and rigid fixation of CMF fractures and reconstruction. Depending on the selected module, the design of the devices is more suitable for specific indications within the broad indication of CMF fractures and CMF reconstructive surgeries.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Eligible patients will be identified as having had a surgical procedure involving the Subject Device.

You may qualify if:

  • Skeletally mature patients at the time of surgery.
  • Patients who underwent a craniomaxillofacial procedure using implants of the Upper-Face and/or Mid-Face modules (1.2 / 1.7 modules) of the Stryker Universal CMF System as per routine clinical practice.
  • Patients for whom data on the primary outcome variable is available.
  • Patients with data available from follow-up visits.

You may not qualify if:

  • Patients with active infections at the time of surgery.
  • Patients with known metal allergies and/or foreign body sensitivity at the time of surgery.
  • Subjects with non-reducible and unstable fractures (except reconstruction plates) at the time of surgery that were treated with the subject devices.
  • Patients who underwent secondary reconstructions with non-secondary reconstruction plates
  • Patients with limited blood supply or insufficient quality or quantity of bone at the time of surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Weill Cornell Medicine Oral and Maxillofacial Surgery 525 East 68th Street, F-2132

New York, New York, 10065, United States

Location

MeSH Terms

Conditions

Zygomatic FracturesOrbital FracturesMaxillary Fractures

Condition Hierarchy (Ancestors)

Maxillofacial InjuriesFacial InjuriesCraniocerebral TraumaTrauma, Nervous SystemNervous System DiseasesSkull FracturesFractures, BoneWounds and InjuriesJaw Fractures

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 7, 2025

First Posted

November 24, 2025

Study Start

March 28, 2025

Primary Completion

March 27, 2026

Study Completion

March 27, 2026

Last Updated

April 22, 2026

Record last verified: 2026-04

Locations